ScinoPharm Taiwan Ltd
TWSE:1789

Watchlist Manager
ScinoPharm Taiwan Ltd Logo
ScinoPharm Taiwan Ltd
TWSE:1789
Watchlist
Price: 17.2 TWD -1.43% Market Closed
Market Cap: 13.6B TWD

Intrinsic Value

The intrinsic value of one ScinoPharm Taiwan Ltd stock under the Base Case scenario is hidden TWD. Compared to the current market price of 17.2 TWD, ScinoPharm Taiwan Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

ScinoPharm Taiwan Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
ScinoPharm Taiwan Ltd

Intrinsic Value History
Dive into the past to invest in the future

ScinoPharm Taiwan Ltd looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether ScinoPharm Taiwan Ltd usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about ScinoPharm Taiwan Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ScinoPharm Taiwan Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for ScinoPharm Taiwan Ltd.

Explain Valuation
Compare ScinoPharm Taiwan Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ScinoPharm Taiwan Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
ScinoPharm Taiwan Ltd

Current Assets 5.4B
Cash & Short-Term Investments 2.9B
Receivables 478.7m
Other Current Assets 2.1B
Non-Current Assets 6.9B
Long-Term Investments 2B
PP&E 4.2B
Intangibles 16.8m
Other Non-Current Assets 713.8m
Current Liabilities 689.6m
Accounts Payable 112m
Accrued Liabilities 106.5m
Short-Term Debt 139.5m
Other Current Liabilities 331.6m
Non-Current Liabilities 629.4m
Long-Term Debt 612.6m
Other Non-Current Liabilities 16.8m
Efficiency

Free Cash Flow Analysis
ScinoPharm Taiwan Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
ScinoPharm Taiwan Ltd

Revenue
3.2B TWD
Cost of Revenue
-2.1B TWD
Gross Profit
1.1B TWD
Operating Expenses
-975.1m TWD
Operating Income
165.4m TWD
Other Expenses
27.1m TWD
Net Income
192.4m TWD
Fundamental Scores

Profitability Score
Profitability Due Diligence

ScinoPharm Taiwan Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
Sustainable 3Y Average Gross Margin
Sustainable 3Y Average Operating Margin
Low 3Y Average Net Margin
hidden
Profitability
Score

ScinoPharm Taiwan Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

ScinoPharm Taiwan Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
High Interest Coverage
Short-Term Solvency
Long-Term Solvency
hidden
Solvency
Score

ScinoPharm Taiwan Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
ScinoPharm Taiwan Ltd

Wall Street analysts forecast ScinoPharm Taiwan Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ScinoPharm Taiwan Ltd is 21.42 TWD with a low forecast of 21.21 TWD and a high forecast of 22.05 TWD.

Lowest
Price Target
21.21 TWD
23% Upside
Average
Price Target
21.42 TWD
25% Upside
Highest
Price Target
22.05 TWD
28% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ScinoPharm Taiwan Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one ScinoPharm Taiwan Ltd stock?

The intrinsic value of one ScinoPharm Taiwan Ltd stock under the Base Case scenario is hidden TWD.

Is ScinoPharm Taiwan Ltd stock undervalued or overvalued?

Compared to the current market price of 17.2 TWD, ScinoPharm Taiwan Ltd is hidden .

Back to Top